How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Read Also
- Udlap students denounce intimidating calls from new board of trustees Jul 11, 2021
- HS analysis How do you break the vicious circle so that busy caregivers can cope with their work? Recruitment bans are just on Sep 15, 2021
- The Attorney General’s Office issued a series of recommendations to the voting juries May 29, 2022
- Two women overwhelmed and killed in a field. The cousin: “They were with two friends, where did they go?” Jul 5, 2021
- Animals Bats chatter like human babies: rhythmically repeating syllables that don’t always matter Aug 20, 2021
- George Moustaki : this nickname mocking during his romance with Edith Piaf May 23, 2020
- Almost 80% of students pass the extraordinary phase of the Ebau in the Region of Murcia Jul 7, 2021